Yonsei Med J.  2008 Oct;49(5):742-747. 10.3349/ymj.2008.49.5.742.

The Effects of Etodolac, Nimesulid and Naproxen Sodium on the Frequency of Sister Chromatid Exchange after Enclused Third Molars Surgery

Affiliations
  • 1Department of Oral Surgery, Istanbul University, Faculty of Dentistry, Istanbul, Turkey. banugr@gmail.com
  • 2Department of Internal Medicine, Istanbul University, Istanbul Medical Faculty, Division of Medical Genetics, Istanbul, Turkey.

Abstract

PURPOSE
Non-steroidal anti-inflammatory drugs (NSAID) are frequently used in oral surgical procedures in dentistry. The evaluation of the frequency of sister chromatid exchange (SCE) is accepted as a reliable cytogenetic method to assess the genotoxic effects of environmental factors. MATERIALS AND METHODS: In this study, the genotoxic effects of various NSAIDs were assessed in 30 patients to who they were administered following encluosed third molar surgery using SCE analysis before and after the operation. The frequency of SCE was evaluated before the operation and after 3 days of etodolac, nimesulid and naproxen use. RESULTS: There was no statistically significant difference in the frequency of SCE between the preoperative and postoperative states in patients given etodolac, nimesulid or naproxen sodium. CONCLUSION: Short term use of selective and non-selective NSAIDs was not associated with a significant genotoxic effect that could be detected using the SCE method in peripheric lymphocytes.

Keyword

Genotoxicity; sister chromatid exchange; oral surgery; non-steroidal anti-inflammatory drugs

MeSH Terms

Adult
Anti-Inflammatory Agents, Non-Steroidal/*adverse effects
Etodolac/adverse effects
Female
Humans
Male
Molar, Third/*surgery
Mutagenicity Tests
Naproxen/adverse effects
Prospective Studies
Sister Chromatid Exchange/*drug effects
Sulfonamides/adverse effects

Figure

  • Fig. 1 In the normal state, one of the sister chromatids is stained dark, while the other is stained light. When a reciprocal change occurs, a dark segment and its homologue light counterpart change places leading to alternating dark and light regions throughout the chromatids.

  • Fig. 2 Comparison of sister chromatid exchange frequencies was performed between the preoperative and postoperative values for etodolac, nimesulid and naproxen sodium.


Cited by  1 articles

Comparison of safety and analgesic efficacy of diclofenac sodium with etodolac after surgical extraction of third molars: a randomized, double-blind, double-dummy, parallel-group study
Jitendra H. Vaghela, Jigna H. Shah, Jaladhi H. Patel, Bhargav M. Purohit
J Dent Anesth Pain Med. 2020;20(1):19-27.    doi: 10.17245/jdapm.2020.20.1.19.


Reference

1. Roux L, Liang MH. Rakel RE, Bope ET, editors. Osteoarthritis. Conn's current therapy 2001. 2000. Philadelphia: WB Saunders Company;969–970.
2. Reynolds JEF, editor. Martindle, the extra pharmacopoeia, nonsteroidal anti-inflammatory drugs. 1996. 31st ed. London: The Pharmaceutical Press;72–75.
3. Balfour JA, Buckley MM. Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs. 1991. 42:274–299.
4. Thomson PDR, editor. USPDI Drug information for the health care professional. 1997. Vol. 1:17th ed. Massachusetts: 379–394.
5. McEvoy GK, editor. American Hospital formulary service drug information 2000. 2005. Bethesda, MO: American Society Health-System Pharmacists;1854–1860.
6. Scott R, Ellis E 3rd, Upton LG. Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain. Oral Surg Oral Med Oral Pathol. 1986. 62:638–642.
Article
7. Giglio JA, Campbell RL. Comparison of etodolac, zomepirac, and placebo for relief of pain after oral surgery. J Oral Maxillofac Surg. 1986. 44:765–770.
Article
8. Fusetti G, Magni E, Armandola MC. Tolerability of nimesulide. Epidemiological data. Drugs. 1993. 46:Suppl 1. 277–280.
9. Lee SH, Norppa H. Effects of indomethacin and arachidonic acid on sister chromatid exchange induction by styrene and styrene-7,8-oxide. Mutat Res. 1995. 348:175–181.
Article
10. Kullich W, Klein G. Investigations of the influence of nonsteroidal antirheumatic drugs on the rates of sister-chromatid exchange. Mutat Res. 1986. 174:131–134.
Article
11. Philipose B, Singh R, Khan KA, Giri AK. Comparative mutagenic and genotoxic effects of three propionic acid derivatives ibuprofen, ketoprofen and naproxen. Mutat Res. 1997. 393:123–131.
Article
12. Özkul Y, Erenmemişoğlu A, Ekecik A, Saatci C, Özdamar S, Demirtaş H. Do non-steroidal anti-inflammatory drugs induce sister chromatid exchanges in T lymphocytes? J Int Med Res. 1996. 24:84–87.
Article
13. Sailer HF, Pajarola GF. Oral surgery for the general dentist. 1999. New York: Georg Thieme Verlag;80.
14. Latt SA. Sister chromatid exchanges, indices of human chromosome damage and repair: detection by fluorescence and induction by mitomycinc. Proc Natl Acad Sci U S A. 1974. 71:3162–3166.
Article
15. Carrano AV, Thompson LH, Lindl PA, Minkler JL. Sister chromatid exchange as an indicator for mutagenesis. Nature. 1978. 271:551–553.
Article
16. De Ferrari M, Artuso M, Bonassi S, Bonatti S, Cavalieri Z, Pescatore D, et al. Cytogenetic biomonitoring of an Italian population exposed to pesticides: chromosome aberration and sister-chromatid exchange analysis in peripheral blood lymphocytes. Mutat Res. 1991. 260:105–113.
Article
17. Moorhead PS, Nowell PC, Mellman WJ, Battips DM, Hungerford DA. Chromosome preparations of leukocytes cultured from human peripheral blood. Exp Cell Res. 1960. 20:613–616.
Article
18. Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 1974. 251:156–158.
Article
19. Perera FP, Whyatt RM. Biomarkers and molecular epidemiology in mutation/cancer research. Mutat Res. 1994. 313:117–129.
Article
20. Dean BJ, Danford N. Venitt S, Parry JM, editors. Assays for the detection of chemically induced chromosome damage in cultured mammalian cells. Mutagenicity testing: A practical approach. 1984. USA: Oxford University Press;187–232.
21. Nakanishi Y, Schneider EL. In vivo sister-chromatid exchange: a sensitive measure of DNA damage. Mutat Res. 1979. 60:329–337.
22. Gebhart E. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Hum Genet. 1981. 58:235–254.
Article
23. Carrano AV, Moore DH. Heddle JA, editor. The rationale methodology for quantifying sister-chromatid exchanges in humans. New horizons in genetic toxicology. 1982. New York: Academic Press;267–304.
Article
24. Rowland RE, Harding KM. Increased sister chromatid exchange in the peripheral blood lymphocytes of young women who smoke cigarettes. Hereditas. 1999. 131:143–146.
25. Barale R, Chelotti L, Davini T, Del Ry S, Andreassi MG, Ballardin M. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age and lifestyle. Environ Mol Mutagen. 1998. 31:228–242.
Article
26. Carbonell E, Peris F, Xamena N, Creus A, Marcos R. SCE analysis in human lymphocytes of a Spanish control population. Mutat Res. 1995. 335:35–46.
Article
27. Öztürk Ş, Palanduz Ş, Aktan M, Çefle K, Serakinci N, Perkçelen Y. Sister chromatid exchange frequency in B-cells stimulated by TPA in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2000. 123:49–51.
Article
28. Palanduz Ş, Sever MŞ, Öztürk Ş, Taşçıoğlu C, Karan MA, Sönmez G, et al. Genotoxic potential of cyclosporine A in patients with renal transplantation. Cell Biol Toxicol. 1999. 15:13–17.
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr